Estonia Pharmaceuticals & Healthcare Q1 2021
We hold an improved outlook for health spending in Estonia as greater resources are allocated to the healthcare systemamid the coronavirus pandemic. However, existing shortages of vital medicines will continue to impact healthcare outcomes forpatients in Estonia. The country’s drug shortages will only be made worse by the pandemic, in addition to the newly implementedpharmacy ownership reforms, as some pharmacies close due to either staff quarantining. Nonetheless, we maintain a relativelypositive long-term outlook for medicine spending growth as healthcare funding continues to increase.